|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2021
12 months to Feb 28, 2022
|
FY2020
12 months to Feb 28, 2021
|
FY2019
12 months to Feb 29, 2020
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Operating expenses | |||||
| General and administrative | |||||
| Research and development | |||||
| Depreciation expense | |||||
| Total operating expenses | |||||
| Operating income (loss) | |||||
| Financing costs (Notes 4 and 6) | |||||
| Loss on settlement of debt (Notes 4 and 6) | |||||
| Other income (expenses) | |||||
| Loss on debt settlement | |||||
| Interest expense | |||||
| Foreign currency exchange gain (loss) | |||||
| Gain on sale of equipment | |||||
| Loss on debt conversion settlements | |||||
| Total other income (expenses) | |||||
| Net Income from Continuing Operations | |||||
| Operating Loss on Discontinued Operations | |||||
| Net Loss from Discontinued Operations | |||||
| Net income (loss) | |||||
| Foreign currency translation gain (loss) | |||||
| Comprehensive loss for the year | |||||
| Net loss per share, basic and diluted | |||||
| Weighted average number of shares outstanding | |||||
| Foreign Currency Translation Loss on Continuing Operations | |||||
| Foreign Currency Translation Loss on Discontinued Operations | |||||
| Comprehensive income (loss) | |||||
| Income (Loss) from Continuing Operations | |||||
| Loss from Discontinued Operations | |||||
| Basic | |||||
| Loss from Continuing Operations | |||||
| Loss from Discontinued Operations | |||||
| Diluted | |||||
| Weighted average common shares outstanding, basic | |||||
| Weighted average common shares outstanding, diluted | |||||
Loading...